Find information on thousands of medical conditions and prescription drugs.

Epinephrine

Epinephrine (INN), also epinephrin (both pronounced ep-i-NEF-rin), or adrenaline (BAN) is a hormone and a neurotransmitter. The Latin roots ad-+renes and the Greek roots epi-+nephros both literally mean "on/to the kidney" (referring to the adrenal gland, which secretes epinephrine). Epinephrine is sometimes shortened to epi in medical jargon. more...

Home
Diseases
Medicines
A
B
C
D
E
E-Base
Ecstasy (drug)
Edecrin
Edrophonium
Edrophonium chloride
Efavirenz
Effexor
Eflornithine
Elavil
Eldepryl
Elidel
Eligard
Elitek
Elixomin
Elixophyllin
Ellagic acid
Elmiron
Eloxatin
Elspar
Emtriva
Emylcamate
Enalapril
Enalaprilat
Enalaprilat
Endep
Enflurane
Enoxaparin sodium
Entacapone
Enulose
Epi-pen
Epinephrine
Epirubicin
Epitol
Epivir
Epogen
Eprosartan
Ergocalciferol
Ergoloid Mesylates
Ergotamine
Eryc
Eryped
Erythromycin
Esgic
Eskalith
Esmolol
Estazolam
Estazolam
Estrace
Estraderm
Estradiol
Estradiol
Estradiol valerate
Estring
Estrogel
Estrone
Estrostep
Ethacridine
Ethambutol
Ethchlorvynol
Ethosuximide
Ethotoin
Etiracetam
Etodolac
Etopophos
Etoposide
Etorphine
Evista
Exelon
Exemestane
Hexal Australia
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Epinephrine is a catecholamine, a sympathomimetic monoamine derived from the amino acids phenylalanine and tyrosine. Its ATC code is C01CA24.

William Bates reported in the New York Medical Journal in May 1886 the discovery of a substance produced by the suprarenal gland. Epinephrine was isolated and identified in 1895 by Napoleon Cybulski, Polish physiologist. The discovery was repeated in 1897 by John Jacob Abel. Jokichi Takamine discovered the same hormone in 1900, without knowing about the previous discovery; but, in later years, counterevidence is shown from the experiment note that Kaminaka leaves that the Takamine team is the discoverer of first adrenaline. It was first artificially synthesized in 1904 by Friedrich Stolz.

Actions in the body

Epinephrine plays a central role in the short-term stress reaction—the physiological response to threatening or exciting conditions (see fight-or-flight response). It is secreted by the adrenal medulla. When released into the bloodstream, epinephrine binds to multiple receptors and has numerous effects throughout the body. It increases heart rate and stroke volume, dilates the pupils, and constricts arterioles in the skin and gut while dilating arterioles in leg muscles. It elevates the blood sugar level by increasing hydrolysis of glycogen to glucose in the liver, and at the same time begins the breakdown of lipids in fat cells. Epinephrine has a suppressive effect on the adaptive immune system.

Epinephrine is used as a drug to promote peripheral vascular resistance via alpha-stimulated vasoconstriction in cardiac arrest and other cardiac disrhythmias resulting in diminished or absent cardiac output, such that blood is shunted to the body's core. This beneficial action comes with a significant negative consequence, increased cardiac irritability, which may lead to additional complications immediately following an otherwise successful resuscitation. Alternatives to this treatment include vasopressin, a powerful antidiuretic which also promotes peripheral vascular resistance leading to blood shunting via vasoconstriction, but without the attendant increase to myocardial irritability.

Because of its suppressive effect on the adaptive immune system, epinephrine is used to treat anaphylaxis and sepsis. Allergy patients undergoing immunotherapy can get an epinephrine rinse before the allergen extract is administered, thus reducing the immune response to the adminsitered allergen. It is also used as a bronchodilator for asthma if specific beta-2-adrenergic agonists are unavailable or ineffective. Adverse reactions to epinephrine include palpitations, tachycardia, anxiety, headache, tremor, hypertension, and acute pulmonary edema.

Read more at Wikipedia.org


[List your site here Free!]


Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05% and Tetracaine Hydrochloride 0.5% Topical Spray
From International Journal of Pharmaceutical Compounding, 11/1/04

METHOD OF PREPARATION

1. Calculate the required quantity of each ingredient for the total amount to be prepared.

2. Accurately weigh and/or measure each ingredient.

3. Add the methylparaben, propylparaben and hydroxyethylcellulose to about 90 mL of purified water and mix well.

4. Heat to about 70-80°C with stirring until the ingredients have dissolved.

5. Cool to room temperature and add the lidocaine hydrochloride, epinephrine hydrochloride and tetracainc hydrochloride and stir until dissolved.

6. Add sufficient purified water to volume and mix well.

7. Package and label.

PACKAGING

Package in tight, light-resistant containers.1

LABELING

Keep out of reach of children. Protect from light. Keep in a cool place. For professional use.

STABILITY

A beyond-use date of up to 14 days, when stored in a refrigerator, can be used for this preparation.1

USE

Lidocaine-epinephrine-tetracaine (LET) spray is used to produce local anesthesia in selected patients, generally for minor surgical procedures and emergency room use.

QUALITY CONTROL

Quality-control assessment can include weight/volume, pH, specific gravity, active drug assay, color, clarity, rheological properties/pourability, physical observation and physical stability (discoloration, foreign materials, gas formation, mold growth).2

DISCUSSION

Lidocaine hydrochloride (C^sub 14^H^sub 22^N^sub 2^O.HCl.H2O, MW 288.81) occurs as a white, odorless, crystalline powder with a slightly bitter taste. It is an amide-type local anesthetic with a rapid onset and intermediate duration of action. It is very soluble in water (1:0.7) and in alcohol (1:1.5).2 A 0.5% aqueous solution has a pH in the range of 4.0 to 5.5. It should be protected from light. Approximately 1.16 g of lidocaine hydrochloride is equivalent to 1 g of lidocaine.3

Epinephrine hydrochloride (C^sub 9^H^sub 13^NO^sub 3^.HCl, MW 219.7, adrenaline hydrochloride) is a sympathomimetic agent. Epinephrine hydrochloride injection USP has a pH in the range of 2.5 to 5 and should be protected from light. It should not be used if it contains a precipitate.3

Tetracaine hydrochloride (C^sub 15^H^sub 24^N^sub 2^O^sub 2^.HCl, MW 300.82, amethocaine hydrochloride) occurs as a fine, white, crystalline, odorless powder. It has a slightly bitter taste, which is followed by a sense of numbness. It is hygroscopic and very soluble in water (1:7.5) and soluble in alcohol. A 1% aqueous solution has a pH in the range of 4.5 to 5.5; the USP specifies a pH of 5.0-6.0 for a 1% aqueous solution; the USP injection has a pH in the range of 3.2 to 6.0.2,3

Hydroxyethylcellulose (HEC) occurs as a light tan or cream-to-white-colored, odorless and tasteless powder. HEC is a non-ionic, water-soluble polymer used especially as a thickening agent in ophthalmic formulations. It is soluble in hot or cold water but practically insoluble in acetone, ethanol and most organic solvents. Solutions can be easily made by dispersing HEC in mildly agitated water at room temperature. When the powder has been thoroughly wetted, increasing the temperature to 60-70°C speeds up the dispersion process.4

Methylparaben (C^sub 8^H^sub 8^O^sub 3^, MW 152.15, Methyl hydroxybenzoate, Methyl parahydroxybenzoate) is available as colorless crystals or as a white, crystalline powder that is odorless or almost odorless, and has a slight burning taste. One gram is soluble in 400 mL of water.5

Propylparaben (C^sub 10^H^sub 12^O^sub 3^, MW 18.20, Propyl hydroxybenzoate, Propyl parahydroxybenzoate) is available as a white, crystalline, odorless and tasteless powder. One gram is soluble in 2500 mL of water.6

Purified water is water that is obtained by distillation, ion exchange, reverse osmosis or some other suitable process.7

REFERENCES

1. US Pharmacopeial Convention, Inc. United States Pharmacopeia 27-National Formulary 22. Rockville, MD: US Pharmacopeial Convention, Inc.; 2004: 2345-2349,

2. Allen LV Jr. Standard operating procedure for performing physical quality assessment of oral and topical liquids. IJPC 1999; 3: 146-147.

3. Reynolds JEF, ed. MARTINDALE: The Extra Pharmacopoeia. 30th ed. London: Pharmaceutical Press; 1993: 1-6, 1001-1002, 1010-1014, 1057.

4. Harwood RJ. Hydroxyethylcellulose. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003: 283-286.

5. Reiger MM. Methylparaben. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003: 390-394.

6. Rieger MM. Propylparaben. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003: 526-528.

7. Ellison A, Nash RA, Wilkin MJ. Water. In: Rowe RC, Sheskey PJ, Weller PJ, eds. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003: 672-676.

Copyright International Journal of Pharmaceutical Compounding Nov/Dec 2004
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Epinephrine
Home Contact Resources Exchange Links ebay